Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet
Voglibose, metformin, and gliclazide tablets (0.3mg/500mg/80mg) are a triple-combination antidiabetic medication for adult type 2 diabetes management. This formulation helps regulate blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar monitoring. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar and potential complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to identify and manage these symptoms; maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet
No text provided to rephrase.
Uses of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet
Managing Type 2 Diabetes
Major Benefits of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg tablet whole; do not chew, crush, or divide it. Always take this medication with food.
Common Side effects of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
How Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet works:
Voglibose, metformin hydrochloride, and gliclazide (0.3mg, 500mg, and 80mg, respectively) are combined in Genericart tablets to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg tablets is hazardous to your health.
PregnancyCONSULT YOUR DOCTOR
The combination medication Voglibose, Metformin Hydrochloride, and Gliclazide (0.3mg/500mg/80mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards before recommending this treatment. Patient consultation with their doctor is advised.
Breast feedingCAUTION
The combination medication Voglibose, Metformin Hydrochloride, and Gliclazide (0.3mg, 500mg, and 80mg, respectively) requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Voglibose, metformin hydrochloride, and gliclazide (0.3mg/500mg/80mg) combination tablets require careful administration in individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver disease should use Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg+500mg+80mg tablets cautiously. Dosage modifications may be necessary. A physician's consultation is advised. Treatment for those with mild to moderate liver impairment typically begins with a low dose; however, this medication is unsuitable for patients with severe liver disease.
What if you forget to take Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet :
NA
Facts to Know About Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.3mg + 500mg + 80mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently